Mizuho Maintains Outperform on HCA Healthcare, Lowers Price Target to $475

Benzinga · 2d ago
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $525 to $475.